Cytotoxic Chemotherapy and CD4+Effector T Cells: An Emerging Alliance for Durable Antitumor Effects

被引:45
作者
Ding, Zhi-Chun [1 ]
Zhou, Gang [1 ,2 ]
机构
[1] Georgia Hlth Sci Univ, Canc Immunotherapy Program, Ctr Canc, Augusta, GA 30912 USA
[2] Georgia Hlth Sci Univ, Hematol Oncol Sect, Dept Med, Sch Med, Augusta, GA 30912 USA
来源
CLINICAL & DEVELOPMENTAL IMMUNOLOGY | 2012年
关键词
TUMOR-INFILTRATING LYMPHOCYTES; DISSEMINATED MURINE LEUKEMIA; MYELOID SUPPRESSOR-CELLS; DRAINING LYMPH-NODES; DENDRITIC CELLS; IN-VIVO; IMMUNE-RESPONSE; B-CELL; ADOPTIVE IMMUNOTHERAPY; MEDIATED SUPPRESSION;
D O I
10.1155/2012/890178
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Standard cytotoxic chemotherapy can initially achieve high response rates, but relapses often occur in patients and represent a severe clinical problem. As increasing numbers of chemotherapeutic agents are found to have immunostimulatory effects, there is a growing interest to combine chemotherapy and immunotherapy for synergistic antitumor effects and improved clinical benefits. Findings from recent studies suggest that highly activated, polyfunctional CD4+ effector T cells have tremendous potential in strengthening and sustaining the overall host antitumor immunity in the postchemotherapy window. This review focuses on the latest progresses regarding the impact of chemotherapy on CD4+ T-cell phenotype and function and discusses the prospect of exploiting CD4+ T cells to control tumor progression and prevent relapse after chemotherapy.
引用
收藏
页数:12
相关论文
共 172 条
[1]   Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired [J].
Ahmadzadeh, Mojgan ;
Johnson, Laura A. ;
Heemskerk, Bianca ;
Wunderlich, John R. ;
Dudley, Mark E. ;
White, Donald E. ;
Rosenberg, Steven A. .
BLOOD, 2009, 114 (08) :1537-1544
[2]   IL-7 Promotes CXCR3 Ligand-Dependent T Cell Antitumor Reactivity in Lung Cancer [J].
Andersson, Asa ;
Yang, Seok-Chul ;
Huang, Min ;
Zhu, Li ;
Kar, Upendra K. ;
Batra, Rai K. ;
Elashoff, David ;
Strieter, Robert M. ;
Dubinett, Steven M. ;
Sharma, Sherven .
JOURNAL OF IMMUNOLOGY, 2009, 182 (11) :6951-6958
[3]   CD8+T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells [J].
Antony, PA ;
Piccirillo, CA ;
Akpinarli, A ;
Finkelstein, SE ;
Speiss, PJ ;
Surman, DR ;
Palmer, DC ;
Chan, CC ;
Klebanoff, CA ;
Overwijk, WW ;
Rosenberg, SA ;
Restifo, NP .
JOURNAL OF IMMUNOLOGY, 2005, 174 (05) :2591-2601
[4]   Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy [J].
Apetoh, Lionel ;
Ghiringhelli, Francois ;
Tesniere, Antoine ;
Obeid, Michel ;
Ortiz, Carla ;
Criollo, Alfredo ;
Mignot, Gregoire ;
Maiuri, M. Chiara ;
Ullrich, Evelyn ;
Saulnier, Patrick ;
Yang, Huan ;
Amigorena, Sebastian ;
Ryffel, Bernard ;
Barrat, Franck J. ;
Saftig, Paul ;
Levi, Francis ;
Lidereau, Rosette ;
Nogues, Catherine ;
Mira, Jean-Paul ;
Chompret, Agnes ;
Joulin, Virginie ;
Clavel-Chapelon, Francoise ;
Bourhis, Jean ;
Andre, Fabrice ;
Delaloge, Suzette ;
Tursz, Thomas ;
Kroemer, Guido ;
Zitvogel, Laurence .
NATURE MEDICINE, 2007, 13 (09) :1050-1059
[5]   Characterization of CD4+ CTLs ex vivo [J].
Appay, V ;
Zaunders, JJ ;
Papagno, L ;
Sutton, J ;
Jaramillo, A ;
Waters, A ;
Easterbrook, P ;
Grey, P ;
Smith, D ;
McMichael, AJ ;
Cooper, DA ;
Rowland-Jones, SL ;
Kelleher, AD .
JOURNAL OF IMMUNOLOGY, 2002, 168 (11) :5954-5958
[6]   Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma [J].
Attia, P ;
Maker, AV ;
Haworth, LR ;
Rogers-Freezer, L ;
Rosenberg, SA .
JOURNAL OF IMMUNOTHERAPY, 2005, 28 (06) :582-592
[7]  
AWWAD M, 1988, IMMUNOLOGY, V65, P87
[8]   A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type IIFN signaling following B7 ligation [J].
Baban, B ;
Hansen, AM ;
Chandler, PR ;
Manlapat, A ;
Bingaman, A ;
Kahler, DJ ;
Munn, DH ;
Mellor, AL .
INTERNATIONAL IMMUNOLOGY, 2005, 17 (07) :909-919
[9]   IDO Activates Regulatory T Cells and Blocks Their Conversion into Th17-Like T Cells [J].
Baban, Babak ;
Chandler, Phillip R. ;
Sharma, Madhav D. ;
Pihkala, Jeanene ;
Koni, Pandelakis A. ;
Munn, David H. ;
Mellor, Andrew L. .
JOURNAL OF IMMUNOLOGY, 2009, 183 (04) :2475-2483
[10]   Restoring function in exhausted CD8 T cells during chronic viral infection [J].
Barber, DL ;
Wherry, EJ ;
Masopust, D ;
Zhu, BG ;
Allison, JP ;
Sharpe, AH ;
Freeman, GJ ;
Ahmed, R .
NATURE, 2006, 439 (7077) :682-687